drugset / Trial / NCT00445107
SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the treatment effect of montelukast 10mg on the primary endpoint of Asthma Control Questionnaire(ACQ), over a 8-week period, in persistent asthma patients with or without allergic rhinitis.
Timeline
- Start
- 2005-11-01
- Primary completion
- 2006-05-01
- Completion
- 2006-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 10 mg | — |